首頁 > 市場調查報告書 > 醫療設備

病患監測血糖監測

市場調查報告書

商品編碼

1866416

全球血糖值監測設備市場－2025-2030年預測

Global Blood Glucose Monitoring Devices Market - Forecasts from 2025 to 2030

出版日期: 2025年11月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球血糖值監測設備市場預計將從 2025 年的 150.86 億美元成長到 2030 年的 221.77 億美元，複合年成長率為 8.01%。

受糖尿病患者數量不斷增加、健康意識日益增強以及監測解決方案技術進步的推動，全球血糖值監測設備市場預計將穩定成長。這些設備對於糖尿病管理至關重要，能夠幫助患者和醫護人員追蹤血糖值，從而指導他們做出有關藥物、飲食和運動的明智決策。對持續、精準監測的需求不斷成長，以了解各種因素對糖尿病管理的影響，正是推動市場發展的關鍵因素。

技術創新顯著提升了血糖值監測設備的功能，尤其是攜帶式血糖儀和連續血糖監測儀（CGM）的出現。血糖儀為患者提供了隨時隨地監測血糖值的便利性和靈活性。 CGM 每 5 至 15 分鐘採集一次數據，能夠全面展現血糖值，並支持數據驅動的治療方案製定。這些進步使得即時追蹤和更有效的疾病管理成為可能，從而改善治療效果，尤其對日益成長的全球 2 型糖尿病患者群體而言更是如此。

市場成長的主要促進因素是生活方式的改變，例如不健康的飲食習慣、吸煙和飲酒。這些因素導致糖尿病發生率上升，尤其是第2型糖尿病病例的增加預計將推動對監測設備的需求。此外，患者和康復者健康意識的提高也促使他們採用設備進行主動健康管理。醫院和醫療機構的需求也推動了這一趨勢，他們越來越依賴這些設備來有效監測康復中的患者。

市場按類型、最終用戶、分銷管道和地區進行細分。按類型分類，市場分為連續血糖監測儀 (CGM) 和自我監測設備，其中 CGM 因其數據準確性高和採集頻率高而備受關注。最終用戶包括醫院和門診手術中心，醫院佔據了市場的大部分佔有率，對可靠的監測工具有著迫切的需求。分銷管道分為線上和線下，反映了醫療產品銷售中電子商務的日益成長的趨勢。從地理來看，市場分佈於北美、南美、歐洲、中東和非洲以及亞太地區，並因區域醫療基礎設施和糖尿病盛行率的不同而呈現出不同的成長動態。

競爭格局以Medtronic、雅培、BD 和羅氏等主要企業為特徵。這些公司正透過產品創新、合作和併購等策略來鞏固其市場地位。近期交易和投資凸顯了市場的動態性，各公司致力於拓展產品系列併提陞技術能力，以滿足不斷變化的消費者需求。

總體而言，在技術進步、糖尿病盛行率上升和健康意識增強的推動下，血糖值監測市場預計將穩定成長，並成為全球醫療產業的關鍵細分市場。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024 年）和預測資料（2025-2030 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The global blood glucose monitoring devices market is poised for steady growth, driven by the rising prevalence of diabetes, increasing health consciousness, and technological advancements in monitoring solutions. These devices, critical for managing diabetes, enable patients and healthcare providers to track blood sugar levels, facilitating informed decisions on medication, diet, and exercise. The market is fueled by the growing need for continuous and accurate monitoring to understand how various factors impact diabetes management.

Technological innovations have significantly enhanced the functionality of blood glucose monitoring devices, particularly with the advent of portable glucometers and continuous glucose monitors (CGMs). Glucometers allow patients to monitor their blood sugar levels on the go, offering convenience and flexibility. CGMs, which collect readings every 5 to 15 minutes, provide a comprehensive view of glucose trends, enabling data-driven treatment plans. These advancements have improved patient outcomes by allowing real-time tracking and better disease management, particularly for those with type 2 diabetes, which is seeing a global surge.

A key driver of market growth is the shift in lifestyle patterns, characterized by unhealthy habits such as poor diet, smoking, and alcohol consumption, which contribute to the rising incidence of diabetes. This increase in diabetes cases, particularly type 2, is expected to propel demand for monitoring devices. Additionally, growing health awareness among patients and recovered individuals is boosting the adoption of these devices for proactive health management. Hospitals and healthcare institutions are also driving demand, as they increasingly rely on these devices to monitor recovering patients effectively.

The market is segmented by type, end-user, distribution channel, and geography. By type, it is divided into continuous monitoring devices and self-monitoring devices, with CGMs gaining traction due to their precision and frequency of data collection. End-users include hospitals, ambulatory surgical centers, and others, with hospitals being a significant contributor due to their need for reliable monitoring tools. Distribution channels are categorized into online and offline, reflecting the growing trend of e-commerce in healthcare product sales. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and the Asia Pacific, with varying growth dynamics based on regional healthcare infrastructure and diabetes prevalence.

The competitive landscape features major players such as Medtronic plc, Abbott Laboratories, BD, and F. Hoffmann-La Roche Ltd. These companies are pursuing strategies like product innovation, partnerships, and mergers to strengthen their market position. Recent deals and investments highlight the dynamic nature of the market, with firms focusing on expanding their product portfolios and enhancing technological capabilities to meet evolving consumer needs.

Overall, the blood glucose monitoring devices market is set to grow steadily, driven by technological advancements, increasing diabetes prevalence, and heightened health awareness, positioning it as a critical segment in the global healthcare industry.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Blood Glucose Monitoring Devices Market is analyzed into the following segments:

By Type

Continuous Monitoring Devices
Self-Monitoring Devices
Flash Glucose Monitoring (FGM) Systems

By End-User

Hospitals
Home Care Settings
Clinics/Diagnostic Centers
Ambulatory Surgical Centers
Long-Term Care Facilities
Others

By Distribution Channel

Online
Offline

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY TYPE

5.1. Introduction
5.2. Continuous Monitoring Devices
5.3. Self-Monitoring Devices
5.4. Flash Glucose Monitoring (FGM) Systems

6. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY END-USER

6.1. Introduction
6.2. Hospitals
6.3. Home Care Settings
6.4. Clinics/Diagnostic Centers
6.5. Ambulatory Surgical Centers
6.6. Long-Term Care Facilities
6.7. Others

7. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction
7.2. Online
7.3. Offline

8. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others